Pavel Klymenko, Head of Omnichannel at Viseven, compares three top approaches to pharma communication and elucidates which are here to stay.
Pavel Klymenko
Advertisement
Pavel Klymenko is Head of Omnichannel at Viseven.
Articles by Pavel Klymenko
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Will the Industry Continue to Research Psychedelics?
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
It’s Official: CMS Unveils Big Price Cuts for 15 High-Cost Medicare Drugs in Latest IRA Negotiation Round
4
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
5
